会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 76. 发明授权
    • Hydrolytically degradable polymers and hydrogels made therefrom
    • 水解可降解的聚合物和水凝胶
    • US07074878B1
    • 2006-07-11
    • US10412642
    • 2003-04-10
    • J. Milton HarrisMichael David BentleyXuan ZhaoXiaoming Shen
    • J. Milton HarrisMichael David BentleyXuan ZhaoXiaoming Shen
    • C08G64/00
    • C08G64/0208C08G64/0216C08G64/183
    • A water soluble polymer is provided having two or more oligomers linked to each other by hydrolytically degradable carbonate linkages. The polymer can be hydrolytically degraded into oligomers (e.g., oligomers of ethylene oxide) under physiological conditions. The polymer can be conjugated to biologically active agents such as proteins or peptides to impart improved water solubility, reduced immunogenicity, reduced rate of renal clearance, and increased stability. The polymer is useful in making hydrolytically degradable hydrogels which can be used in drug delivery and related biomedical applications. On example of the polymer is a poly (ether carbonate) of the formula X—O—[(—CH2CH2—O—)n—CO2—]n—(CH2CH2))n-y where X and Y are independently H, alkyl, alkenyl, aryl, or a reactive moiety, and at least one of X and Y is a reactive moiety.
    • 提供了具有两个或多个通过可水解降解的碳酸酯键相互连接的低聚物的水溶性聚合物。 在生理条件下,聚合物可以水解降解成低聚物(例如环氧乙烷的低聚物)。 聚合物可以与生物活性剂如蛋白质或肽缀合以赋予改善的水溶性,降低的免疫原性,降低的肾清除率和增加的稳定性。 该聚合物可用于制备可用于药物递送和相关生物医学应用的水解可降解水凝胶。 聚合物的实例是式XO的聚(醚碳酸酯) - [( - CH 2 CH 2 -O - ) - N - -CO 2 - - - - - (CH 2 CH 2)) - (CH 2 CH 2) -y其中X和Y独立地是H,烷基,烯基,芳基或反应性部分,X和Y中的至少一个是反应性部分。
    • 79. 发明授权
    • Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution
    • 可溶性,可降解的聚(乙二醇)衍生物,用于将结合分子可控地释放到溶液中
    • US06515100B2
    • 2003-02-04
    • US09824297
    • 2001-04-02
    • J. Milton Harris
    • J. Milton Harris
    • A61K3174
    • C08G65/33396A61K47/60C08G65/33317
    • PEG and related polymer derivatives having weak, hydrolytically unstable linkages near the reactive end of the polymer are provided for conjugation to drugs, including proteins, enzymes, small molecules, and others. These derivatives provide a sufficient circulation period for a drug-PEG conjugate and then for hydrolytic breakdown of the conjugate and release of the bound molecule. In some cases, drugs that previously had reduced activity when permanently coupled to PEG can have therapeutically suitable activity when coupled to a degradable PEG in accordance with the invention. The PEG of the invention can be used to impart water solubility, size, slow rate of kidney clearance, and reduced immunogenicity to the conjugate. Controlled hydrolytic release of the bound molecule in the aqueous environment can then enhance the drug delivery system.
    • 提供在聚合物的反应性末端附近具有弱的水解不稳定键的PEG和相关的聚合物衍生物用于与药物(包括蛋白质,酶,小分子等)共轭。 这些衍生物为药物-PEG缀合物提供足够的循环周期,然后用于结合物的水解分解和结合分子的释放。 在一些情况下,当与PEG偶联时,先前具有减少的活性的药物在与根据本发明的可降解的PEG偶联时可具有治疗上合适的活性。 本发明的PEG可用于赋予水溶性,大小,缓慢的肾清除率,降低对缀合物的免疫原性。 在水环境中控制的结合分子的水解释放可以增强药物递送系统。